Indie Asset Partners’s Thermo Fisher Scientific TMO Stock Holding History

Indie Asset Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-526	Closed	-$311K	–	125
2022 Q1	$311K	Hold	526	–	–	0.23%	80
2021 Q4	$351K	Hold	526	–	–	0.25%	80
2021 Q3	$301K	Hold	526	–	–	0.24%	85
2021 Q2	$265K	Hold	526	–	–	0.21%	95
2021 Q1	$240K	Buy	+526	New	+$251K	0.27%	101

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Indie Asset Partners's TMO Position: Q2 2022 in Review

Indie Asset Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 526 shares — an estimated $311K sold.

Indie Asset Partners first reported a position in TMO in Q1 2021 and held it in 5 quarters. The position peaked at $351K in Q4 2021. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Indie Asset Partners reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
Indie Asset Partners sold 526 Thermo Fisher Scientific shares in Q2 2022, an estimated $311K.
Indie Asset Partners first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 5 quarters.
Indie Asset Partners's Thermo Fisher Scientific position peaked at $351K in Q4 2021.
2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Indie Asset Partners's 13F filing for Q2 2022, filed 12 Aug 2022.